T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 3 246.4 INR -0.25% Market Closed
Market Cap: 1.1T INR

Intrinsic Value

The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 948.31 INR. Compared to the current market price of 3 246.4 INR, Torrent Pharmaceuticals Ltd is Overvalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TORNTPHARM Intrinsic Value
1 948.31 INR
Overvaluation 40%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Torrent Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
TORNTPHARM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for TORNTPHARM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
IN
Pharmaceuticals
Market Cap
1.1T INR
IPO
Nov 3, 1994
IN
Pharmaceuticals
Market Cap
1.1T INR
IPO
Nov 3, 1994
Price
₹false
EPS
₹false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TORNTPHARM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Torrent Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Torrent Pharmaceuticals Ltd

Current Assets 58.8B
Cash & Short-Term Investments 14.8B
Receivables 17.9B
Other Current Assets 26.1B
Non-Current Assets 92.1B
Long-Term Investments 650m
PP&E 36.3B
Intangibles 46.7B
Other Non-Current Assets 8.4B
Efficiency

Free Cash Flow Analysis
Torrent Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Torrent Pharmaceuticals Ltd

Revenue
113B INR
Cost of Revenue
-27.2B INR
Gross Profit
85.8B INR
Operating Expenses
-57.4B INR
Operating Income
28.4B INR
Other Expenses
-9.8B INR
Net Income
18.6B INR
Fundamental Scores

TORNTPHARM Profitability Score
Profitability Due Diligence

Torrent Pharmaceuticals Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
ROE is Increasing
67/100
Profitability
Score

Torrent Pharmaceuticals Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

TORNTPHARM Solvency Score
Solvency Due Diligence

Torrent Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
67/100
Solvency
Score

Torrent Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd

Wall Street analysts forecast TORNTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 3 605.89 INR with a low forecast of 2 959.3 INR and a high forecast of 4 200 INR.

Lowest
Price Target
2 959.3 INR
9% Downside
Average
Price Target
3 605.89 INR
11% Upside
Highest
Price Target
4 200 INR
29% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TORNTPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TORNTPHARM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TORNTPHARM stock?

The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 948.31 INR.

Is TORNTPHARM stock undervalued or overvalued?

Compared to the current market price of 3 246.4 INR, Torrent Pharmaceuticals Ltd is Overvalued by 40%.

Back to Top